Clark Wealth Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Clark Wealth Partners's DGX Position: Q3 2026 in Review
Clark Wealth Partners increased its Quest Diagnostics (DGX) stake by 18% in Q3 2026, buying an estimated $693 and bringing the position to 20 shares worth $4.66K. The position accounts for ﹤0.01% of the portfolio, ranked #417.
Clark Wealth Partners first reported a position in DGX in Q1 2025 and has held it in 7 quarters since. 1,007 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Clark Wealth Partners held 20 shares of Quest Diagnostics worth $4.66K as of Q3 2026.
- Clark Wealth Partners bought 3 Quest Diagnostics shares in Q3 2026, an estimated $693.
- Quest Diagnostics made up ﹤0.01% of Clark Wealth Partners's portfolio in Q3 2026, its #417 holding.
- Clark Wealth Partners first reported a position in Quest Diagnostics in Q1 2025 and has held it in 7 quarters since.
- 1,007 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Clark Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.